2m 2m 2m 2m 2m 2m 2m
Acadia Pharma (ACAD)
NASDAQ
$25.34-$0.16 (-0.61%)
Price as of Jul 14, 2026 4:00 AM EDT- $4.5BMarket Cap
- 16.49%1-Year Change
- BiotechnologyIndustry
Acadia Pharma (ACAD)
$25.34-$0.16 (-0.61%)
ACAD | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $25.50 | ||
Change | -$0.72 (-2.75%) | ||
Open | $26.04 | ||
High | $26.04 | ||
Low | $25.30 | ||
Previous Close | $26.22 | ||
Volume | 1,562,833 | ||
30-Day Average Volume | 1,934,762 | ||
1-Week Change | -1.05% | ||
1-Month Change | 20.91% | ||
1-Year Change | 16.49% | ||
3-Year Change | -1.16% | ||
5-Year Change | 6.34% | ||
Fundamentals | |||
Shares Outstanding | 171.2M | ||
Total Assets | $1.6B | ||
Market Cap | $4.5B | ||
Enterprise Value | $4.2B | ||
Period: QTR TTM FY | |||
Revenue | $268.1M | ||
Net Income | $3.6M | ||
Free Cash Flow | $28.8M | ||
EBIT | $4.0M | ||
EBITDA | $6.7M | ||
Net Working Capital | $790.5M | ||
EPS | $0.02 | ||
Enterprise Value/EBITDA | 628 | ||
Enterprise Value/Revenue | 16 | ||
P/B | 4 | ||
P/E | 1,311 | ||
PEG | -13 | ||
Price/Free Cash Flow | 156 | ||
Price/Operating Cash Flow | 132 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue